ImageneBio, Inc. (IMA)
Healthcare
Biotechnology
5.60 $
+1.8%
vs. previous close
Closing price · As of: 3. Aug 2026
ImageneBio, Inc. (IMA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -15 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -18 | -20 | -22 | -18 | -13 | -8.9 | -6.3 | -11 | -3.4 | -27 | -7.2 | -15 | -52 | |
| 0.6 | 0.2 | 0.3 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | -0.2 | 0.4 | 0.2 | 0.4 | |
| 1.9 | 2.0 | 1.8 | 2.0 | 1.3 | 1.0 | 1.0 | 0.9 | 0.5 | 14 | 0.1 | 0.9 | 15 | |
| -2.9 | -4.8 | -6.4 | -5.3 | -0.2 | -0.1 | 1.5 | -3.3 | -1.7 | -13 | -0.9 | -5.2 | -21 | |
| 0.0 | 0.0 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 23 | 32 | 20 | -49 | 3.9 | 9.5 | 0.5 | 7.9 | 25 | -37 | -1.4 | -0.4 | -14 | |
| -0.7 | – | 0.1 | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | 7.5 | – | – | – | 0.0 | – | – | |
| 37 | 39 | 0.1 | – | – | – | 6.9 | 0.0 | – | 135 | 0.0 | -3.2 | – | |
| 42 | 51 | -1.4 | -67 | -8.6 | 0.5 | -5.8 | -2.6 | 22 | 45 | -8.6 | -18 | 39 | |
| -18 | -20 | -22 | -18 | -13 | -8.9 | -6.3 | -11 | -3.4 | -27 | -7.2 | -15 | -52 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.